Published in Eur Urol on February 05, 2013
Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol (2012) 2.80
Treatment of postprostatectomy male urinary incontinence with the transobturator retroluminal repositioning sling suspension: 3-year follow-up. Eur Urol (2012) 2.43
The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence. Eur Urol (2012) 2.37
Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms. Eur Urol (2013) 1.65
Secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot phase II study. World J Urol (2013) 1.42
Prospective, multidimensional evaluation of sexual disorders in men after laser photovaporization of the prostate. J Sex Med (2013) 1.42
Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study. Ann Surg Oncol (2011) 1.42
Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): results from a large French multicenter collaborative study. Ann Surg Oncol (2011) 0.98
Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Hum Genet (2015) 0.95
Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study. Eur Urol (2013) 0.86
The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database. World J Urol (2012) 0.83
Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study. Int Urogynecol J (2010) 0.82
Pelvic organ prolapse transvaginal repair by the Prolift system: evaluation of efficacy and complications after a 4.5 years follow up. Int J Urol (2012) 0.82
First clinical evaluation of a new innovative ureteral access sheath (Re-Trace™): a European study. World J Urol (2013) 0.80
Evolution of the landscape of surgical management of prostate cancer in France: the case of radical prostatectomy. Eur Urol (2012) 0.80
Serum sex steroids measured in middle-aged European and African-Caribbean men by gas chromatography-mass spectrometry. Eur J Endocrinol (2011) 0.80
Nocturnal polyuria: it's all about definition, and be Patient! Eur Urol (2012) 0.79
TVT SECUR single-incision sling after 5 years of follow-up: the promises made and the promises broken. Eur Urol (2012) 0.78
Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med (2012) 0.77
Antegrade percutaneous flexible endoscopic approach for the management of urinary diversion-associated complications. J Endourol (2013) 0.77
LUTS (R)evolution: let's jump on the bandwagon. Eur Urol (2013) 0.76
Comparative effectiveness research in urology: a step toward better therapeutic decision making. Eur Urol (2012) 0.75
Mirabegron as a new class of oral drug for overactive bladder syndrome: many positive perspectives, some concerns. Eur Urol (2012) 0.75
Mini-slings for female stress urinary incontinence: not yet at the age of reason. Eur Urol (2011) 0.75
Urinary incontinence symptoms stratification: the devil is in the details. Eur Urol (2011) 0.75
[Two major diagnostic innovations in the management of prostate cancer]. Prog Urol (2007) 0.75
[Trends in the management of prostate cancer over the last 20 years]. Prog Urol (2007) 0.75
Pyonephrosis Caused by Salmonella Typhi: A Case Report. Urol Int (2014) 0.75
[LHRH agonists in prostate cancer]. Prog Urol (2007) 0.75
Have mini-slings come of age? Curr Opin Urol (2015) 0.75